What’s really happening with GLP-1s? What real-world data tells us.

GLP-1s are among today’s most talked about drugs, but who is using them and how well are they working? Don’t miss this live session that will explore findings from studies on GLP-1s using Truveta Data to reveal key trends in use, effectiveness, and access.

Join us for expert insights into:

Capturing faster, more comprehensive insights with Truveta Data.
Understanding the trends in GLP-1 use over time and across diverse demographics.
Interpreting patterns of GLP-1 discontinuation and reinitiation and key influencing factors.
Understanding differences in on-treatment weight change between tirzepatide and semaglutide for type 2 diabetes.
Generating these types of insights for other drugs, diseases, or devices.

Register for the report

Your Company Email Address

Please select your industry: (max 1)

Ask a question early:

Opt In?

You agree Citeline and Truveta may contact you directly about industry news, products, services and events that may be of interest to you subject to the privacy policies of Citeline and Truveta.